Vivek Yerrapu Reddy, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: EBR(SIGNIFICANT), Biosense-Webster(SIGNIFICANT), Medtronic-Cryocath(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Impulse Dynamics(SIGNIFICANT), Philips(MODEST), Abbott Inc(SIGNIFICANT), Cardionomiccs(SIGNIFICANT), CardioNXT(SIGNIFICANT), AFTx(SIGNIFICANT), Biotronik(SIGNIFICANT), AtriAN(SIGNIFICANT), Fire1(SIGNIFICANT), CoreMap(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Surecor(SIGNIFICANT), kardium(SIGNIFICANT), Newtrace(SIGNIFICANT), CoRISMA(SIGNIFICANT), Restore Medical(SIGNIFICANT), Dinova Hangzhou Nuomao Medtech, Ltd(SIGNIFICANT), Intershunt(SIGNIFICANT), HRT(SIGNIFICANT), CardiaCare(SIGNIFICANT), APN Health(SIGNIFICANT), Biostar Ventures(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Manual Surgical Sciences, Inc(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Epix Therapeutics(SIGNIFICANT), Acutus Medical(SIGNIFICANT), Affera Inc(SIGNIFICANT), Apama Medical(SIGNIFICANT), Autonomix Inc(SIGNIFICANT), Biosig Inc(SIGNIFICANT), Circa(SIGNIFICANT), Farapulse(SIGNIFICANT), Middlepeak(SIGNIFICANT), VytronUS(SIGNIFICANT), Keystone(SIGNIFICANT), Valcare(SIGNIFICANT), Medlumics(SIGNIFICANT), LuxCath(SIGNIFICANT), Corvia Medical(SIGNIFICANT), EP Dynamics(SIGNIFICANT), Epi EP(SIGNIFICANT), Javelin(SIGNIFICANT), Axon(SIGNIFICANT), Backbeat(SIGNIFICANT), East End Medical(SIGNIFICANT), Eximo(SIGNIFICANT), Newpace(SIGNIFICANT)

View Full Disclosure